Most households can say how many days of food and water they have and go blank on medication. Here is how to work out your number, why the generic supply chain is thinner than it looks, and the legitimate ways to build a buffer before you need one.
Ask a prepared household how many days of water they hold and you will get a number. Ask how many days of prescription medication and the answer is usually a pause. The bottle is in the cabinet, the refill is automatic, and nobody has counted.
It is worth counting, because medication behaves differently from every other supply. You cannot substitute it, you cannot stretch it safely, and you cannot buy more on the way home when the pharmacy has none. For anyone on a daily prescription it is the shortest and least visible line in the whole plan.
Start with the plain arithmetic. Count the doses you physically have, divide by what you take each day, and write the number down. That is your real figure, not the refill date on the label. Do it for every person in the house, and for pets on long-term medication too.
Your MyPlann plan already tracks prescriptions and reports your days on hand in every scenario summary. If you have not entered them, that is the single most useful gap to close.
Generic medicines are about ninety percent of all prescriptions filled in the United States, and a large share of them are made elsewhere. India supplies more than half of the generic prescriptions filled in the US. For some everyday ingredients the concentration is sharper still: China accounts for roughly ninety-five percent of imported ibuprofen, seventy percent of acetaminophen, and as much as forty-five percent of imported penicillin.
That concentration sits on top of an unusual economic problem. Generics compete almost entirely on price, so margins are thin by design. Mariana Socal at Johns Hopkins has pointed out that those slim margins limit a manufacturer's ability to absorb any added cost, which tends to arrive at the patient instead.
The quiet failure mode is not a price rise. It is a manufacturer deciding a low-margin product is no longer worth making and simply stopping. One supplier leaving a market with only two or three suppliers is how a common drug becomes unavailable for months, and it happens without any announcement.
President Trump has announced tariffs on imported generic drugs of one hundred percent beginning in August 2028, rising to two hundred percent a year later. The stated purpose is to move generic pharmaceutical production back to the United States, with the tariff acting as a penalty on companies that do not build domestic capacity within that window.
The dates matter, and they are the part most coverage skips. Nothing changes at the pharmacy counter this month because of this policy. What is being argued about is what happens toward the end of the decade, and whether the industry responds by building plants or by walking away.
Marta Wosinska of the Brookings Institution has warned about the second possibility, that there may not be enough incentive to onshore, not enough capacity if the tariffs arrive, and that manufacturers may simply leave the market. A Brookings analysis also raised the concern that cost-cutting to absorb tariffs could affect the quality of generic drugs. The Association for Accessible Medicines, which represents generic makers, has emphasised investment the industry has already made in US supply.
For a household the practical reading is narrow. Treat this as a reason to know your number and to build a sensible buffer through your prescriber, not as a reason to do anything sudden. Shortages that already exist are the near-term problem; the tariff is a slower pressure on the same system.
Everything worth doing here runs through your prescriber or pharmacist. There is no safe version of rationing your own doses, skipping days to build a reserve, or buying prescription medicine from an unverified overseas seller. Those turn a supply problem into a health problem.
The legitimate routes are ordinary and worth asking about by name. A ninety-day fill instead of thirty days immediately triples what is in the house. Many plans allow an early refill for travel, sometimes called a vacation override, and some states allow an emergency refill when a pharmacy cannot reach your prescriber. Mail-order fills often come in larger quantities. Ask which of these your plan and your state allow before you need them.
Rotate what you hold rather than hoarding it. Filling a few days early each cycle builds a buffer that stays in date, and nothing sits at the back of a cupboard expiring. Keep the buffer where you would actually reach it, not in a bathroom, where heat and humidity are hardest on medication.
Write down the list itself. Drug names, doses, strengths, the prescribing doctor and the pharmacy, kept somewhere you can reach without power. If you are ever treated somewhere unfamiliar, or have to ask a different pharmacy to help, that page does more work than the pills.
The FDA publishes a public drug shortage database, and the American Society of Health-System Pharmacists maintains its own list. Both are searchable by drug name and both say whether a shortage is active and why. Checking yours takes a minute and is more reliable than asking around.
If yours is listed, act earlier than feels necessary. Your pharmacist can often see stock at other branches or order through a different wholesaler, and that conversation goes better with a week of doses left than with one. Ask your prescriber whether a different strength, a different form, or a therapeutic alternative would work for you, and ask while there is still time to try it.
The general rule holds for medication as it does for everything else in a plan. The moment to solve a supply problem is while it is still an inconvenience.
MyPlann maps your real preparedness level against every scenario in this brief — and shows you exactly what to address first. Free during early access.
Free during early access. No spam, ever.